However, survival rates have also increased for certain BC subtypes, particularly the early-stage hormone-sensitive BC subtype with overexpression of the estrogen α receptor, which responds to up to 70% to hormonal therapies such as estrogen receptor blockers or aromatase inhibitors that suppress estrogen synthesis [3,4]. The gene discussed is ESR1; the disease is breast cancer.